American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research jointly filed an amended beneficial ownership statement with the SEC on November 16, 2026, reporting a combined 1,152,357 shares of Blue Bird Corporation common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: The three reporting persons each reported 1,152,357 shares of Blue Bird Corporation common stock, representing 3.6% of the class.
  • Sole voting power: American Century Investment Management, Inc. reported sole voting power over 1,132,603 shares, with zero shares subject to shared voting power.
  • Sole dispositive power: Each reporting person reported sole dispositive power over 1,152,357 shares, with no shared dispositive power reported.
  • Event date: The date of the event requiring the filing was September 30, 2026, according to the document.
  • Corporate structure: The filing disclosed that American Century Investment Management, Inc. is a wholly-owned subsidiary of American Century Companies, Inc., which is controlled by Stowers Institute for Medical Research.
  • Client accounts: The filing noted that various investment company and separate institutional investor accounts advised by American Century Investment Management, Inc. have the right to receive or direct dividends or sale proceeds from the reported securities, with no single client holding more than 5% of the class.

American Century Discloses Ownership Position in Blue Bird Corporation

Blue Bird Corporation, headquartered at 3920 Arkwright Road, Suite 200, Macon, Georgia 31210, is the issuer of the common stock reported in this filing. The amendment was filed jointly by American Century Investment Management, Inc. (ACIM), a Delaware-organized registered investment adviser; American Century Companies, Inc. (ACC), a Delaware-organized holding company; and Stowers Institute for Medical Research, a Delaware-organized entity that the filing describes as the control entity of ACC. All three reporting persons share the same principal business address at 4500 Main Street, 9th Floor, Kansas City, Missouri 64111.

According to the filing, ACIM is classified as an investment adviser (type "IA") and is a wholly-owned subsidiary of ACC. ACC and Stowers Institute for Medical Research are each classified as holding companies (type "HC"). The filing states that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." The joint filing was executed under a consent agreement in which ACC and Stowers Institute for Medical Research authorized ACIM to file on their behalf, with signatures provided by John Pak, Senior Vice President of both ACIM and ACC, dated November 16, 2026.

The filing is designated Amendment No. 1 to a prior Schedule 13G. No shared voting or shared dispositive power was reported by any of the three filers. The difference between the sole voting figure of 1,132,603 shares and the aggregate beneficial ownership figure of 1,152,357 shares reflects shares over which ACIM holds dispositive but not voting authority, as reported in the document.

What Was Disclosed

Three affiliated entities filed an amended ownership statement disclosing a combined 1,152,357 shares, or 3.6%, of Blue Bird Corporation common stock, with the triggering event dated September 30, 2026 and the filing submitted on November 16, 2026.